Orally Administered Enoxaparin Ameliorates Acute Colitis by Reducing Macrophage-Associated Inflammatory Responses
Inflammatory bowel diseases, such as ulcerative colitis, cause significant morbidity and decreased quality of life. The currently available treatments are not effective in all patients, can be expensive and have potential to cause severe side effects. This prompts the need for new treatment modaliti...
Published in: | PLoS ONE |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Published: |
Public Library of Science
2015
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84941899070&doi=10.1371%2fjournal.pone.0134259&partnerID=40&md5=8e91ec065eab8f578844552d60b07c64 |